ScholarIQanswers from OpenAlex & ORCID
Frede Donskov
ResearcherPublications, citations & collaboration network
Frede Donskov is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Frede Donskov have?
ScholarIQindexed works
Frede Donskov has 377 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Frede Donskov have?
ScholarIQcitation count
Frede Donskov has 29,757 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Frede Donskov?
ScholarIQh-index
Frede Donskov has an h-index of 63 in OpenAlex.
What is the i10-index of Frede Donskov?
ScholarIQi10-index
Frede Donskov has an i10-index of 171 in OpenAlex.
What is the ORCID of Frede Donskov?
ScholarIQorcid
The ORCID for Frede Donskov is on the source record.
What is the OpenAlex record for Frede Donskov?
ScholarIQopenalex
The OpenAlex for Frede Donskov is on the source record.
What are the most-cited papers on Frede Donskov?
ScholarIQmost cited works
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Robert J. Motzer, Bernard Escudier, Ray McDermott, Saby George, Hans J. Hammers, Sandhya Srinivas, Scott S. Tykodi, Jeffrey A. Sosman, Giuseppe Procopio, Elizabeth R. Plimack, Daniel Castellano, Toni K. Choueiri, Howard Gurney, Frede Donskov, Petri Bono, John Wagstaff, Thomas Gauler, Takeshi Ueda, Yoshihiko Tomita, Fabio A.B. Schutz, Christian Kollmannsberger, James Larkin, Alain Ravaud, Jason S. Simon, Li-An Xu, Ian M. Waxman, Padmanee Sharma
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Robert J. Motzer, Nizar M. Tannir, Ray McDermott, Osvaldo Arén Frontera, Bohuslav Melichar, Toni K. Choueiri, Elizabeth R. Plimack, Philippe Barthélémy, Camillo Porta, Saby George, Thomas Powles, Frede Donskov, Victoria Neiman, Christian Kollmannsberger, Pamela Salman, Howard Gurney, Robert D. Hawkins, Alain Ravaud, Marc‐Oliver Grimm, Sergio Bracarda, Carlos H. Barrios, Yoshihiko Tomita, Daniel Castellano, Brian I. Rini, Allen C. Chen, Sabeen Mekan, M. Brent McHenry, Megan Wind‐Rotolo, Justin Doan, Padmanee Sharma, Hans J. Hammers, Bernard Escudier
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study
Jenny J. Ko, Wanling Xie, Nils Kroeger, Jae-lyun Lee, Brian I. Rini, Jennifer J. Knox, Georg A. Bjarnason, Sandy Srinivas, Sumanta K. Pal, Takeshi Yuasa, Martin Smoragiewicz, Frede Donskov, Ravindran Kanesvaran, Lori Wood, D. Scott Ernst, Neeraj Agarwal, Ulka N. Vaishampayan, Sun Young Rha, Toni K. Choueiri, Daniel Y.C. Heng
Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival
Shaan Dudani, Guillermo de Velasco, J. Connor Wells, Chun Loo Gan, Frede Donskov, Camillo Porta, Anna Paola Fraccon, Felice Pasini, Jae‐Lyun Lee, Aaron R. Hansen, Georg A. Bjarnason, Benoit Beuselinck, Sumanta K. Pal, Takeshi Yuasa, Nils Kroeger, Ravindran Kanesvaran, M. Neil Reaume, Christina Canil, Toni K. Choueiri, Daniel Y.C. Heng